Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tachycardia

Inclusion criteria

• ≥18 years old
• Patient with the following:

• Evidence of post-myocardial infarction* structural heart disease.
• Cardiac CT and/or cardiac MRI scan performed within 6 months.
• ICD/CRTD implantation.
• Device therapy for VT: at least 1 appropriate ICD shock or 3 ATP episodes within a 6-month period.
• Suitable candidate for VT ablation as per NHS standard of care.
• Patient agrees to comply with study procedures and be available for routine follow up visits for at least 6 months after enrolment.

Exclusion criteria

• Lacks capacity to provide informed consent.
• Presence of intramural thrombus, tumour or abnormality that precludes vascular access, catheter introduction or manipulations.
• Coagulopathy, bleeding diathesis or suspected pro-coagulant state.
• Sepsis, active systemic infection or fever (>100.5 F/38 C) within a week prior to the ablation procedure.
• Renal failure requiring dialysis or renal compromise that in the investigator's judgement would increase risk to the patient or deem the patient inappropriate to participate in the study.
• Known allergies or intolerance to AADs to be used to treat PVCs.
• Known allergy for contrast.
• Female patients who are pregnant or breast feeding.
• Enrolment in a concurrent interventional clinical study that in the judgement of the investigator would increase risk to the patient or deem them inappropriate to participate in this study.
• Other conditions that may prevent patients from adhering to the study protocol, in the opinion of the investigator.